Artificial Intelligence (AI)

What Is Neuralink? The N1 Implant, Telepathy and Blindsight, Explained

A cyanotype print in deep Prussian blue and white of a vintage theremin standing alone on a plain wooden stand, its upright antenna and side loop casting soft pale outlines, an instrument played without touch, used as a visual for Neuralink, the brain implant company whose Telepathy trials let people with paralysis control a computer cursor by thought

Neuralink is Elon Musk’s brain implant company. Its first product, Telepathy, lets people with paralysis control a computer cursor by thought. As of November 2026, every Neuralink device is still investigational. None is approved for sale, and the company publishes no price.

The company has been in human trials since January 2024. It now runs studies in the United States, Canada, the UK and the United Arab Emirates. A speech study runs in Texas. On October 30, Musk posted on X that Blindsight, a vision implant, is waiting only on regulatory approval. That claim is his, and the company’s own pages do not yet show a Blindsight trial.

The short version: Neuralink is a wireless implant placed by a robot, used today in small feasibility studies. Participants move a cursor and click on a computer the company provides. For agencies and nonprofits, the near-term lesson is simple. People using brain-computer interfaces operate your site with a pointer. The accessibility basics you already follow are what help them.

This piece covers the implant, the robot, Telepathy, the speech study, Blindsight and the trial sites. Then it covers what this means for digital products. It sticks to what Neuralink, ClinicalTrials.gov and regulators state. It is not medical advice.

What Neuralink builds

The company’s technology page describes a brain-computer interface with two parts: an implant and a surgical robot. The implant records signals from neurons and sends them wirelessly to an app. The app turns that data stream into actions, such as cursor movement.

The company’s name for the implant is the N1. In the registry entries on ClinicalTrials.gov, the devices are listed as the N1 Implant and the R1 Robot.

According to the technology page, the N1 has four main parts:

  • A sealed, biocompatible enclosure.
  • A small battery charged wirelessly through the scalp.
  • Custom low-power chips that process signals and transmit them.
  • Flexible, ultra-thin electrode threads that record activity in the brain.

The company says the implant "sits flush within the skull" with no wires, connectors or external battery pack. Its trial pages say one hour of charging gives four to eight hours of use, depending on the implant version. Participants get a hat with a pouch for the charger.

How the robot places the Neuralink implant

The threads are too fine to insert by hand, the company says, so its R1 robot does it. The technology page lists a robot head with five camera systems and optical coherence tomography optics. Its needle is "thinner than a human hair" and grasps, inserts and releases each thread.

The company’s September 2023 trial announcement says the robot places the threads in a brain region that controls movement intention. The same post says the study runs under an investigational device exemption the FDA granted in May 2023.

The company has been open about one early problem. In its January 2026 update, it says the first participant’s implant showed thread retraction. It says later surgical changes improved signal quality in 18 of the next 20 participants.

What Telepathy does

Telepathy is the product name for computer control. Neuralink’s January 2026 update says "Our first product, Telepathy" in its opening lines. Musk repeated that framing in his October 30 post: "Neuralink’s first product is called Telepathy."

The Telepathy trial page explains how it works. The implant listens to the part of the brain that controls the hand. Participants imagine moving their hand, and those signals are calibrated into mouse actions.

What participants can do today, per that page:

  • Move a cursor and use left, right and middle click.
  • Use a MacBook that Neuralink provides. Phone, Windows and game console control are still being developed.
  • Test experimental features such as a keyboard, wheelchair or robotic arm control. These are not available to all participants.

Learning time varies. The company says some participants gain fluent control on day one, while others take a few weeks. Keeping control can take up to a few hours of calibration per week.

The company also reports speed. Its January update says able-bodied mouse users average about 8 to 10 bits per second on its Webgrid test. Several participants reached or passed that range. These are the company’s own measurements.

Speech: the VOICE study

The second active trial targets speech. The speech restoration page says the implant reads the speech motor cortex. Participants attempt or imagine speaking, and a decoder turns that into text.

The text appears in the Neuralink iOS app. From there it can be sent as a message or spoken aloud in a re-created version of the person’s original voice.

The company says its median participant decodes about 50 words per minute. It compares that with about 8 for eye-gaze typing and about 150 for natural conversation. The FDA gave the speech device Breakthrough Device Designation, according to Neuralink’s May 2025 post. That designation speeds up FDA review. It is not an approval.

Where Blindsight stands

Blindsight is the vision project. Neuralink’s September 2024 post says the FDA gave it Breakthrough Device Designation "for individuals with vision impairment."

That is the last formal status the company has published. As of November 2, 2026, Neuralink’s clinical trials page lists only the device control and speech studies. A ClinicalTrials.gov search for Blindsight returns no Neuralink study.

Musk says more. In his October 30 post on X, he called Blindsight the second product and wrote: "It is ready from an engineering standpoint. Just waiting on regulatory approval." The same post says it will let people who are completely blind see. Treat both statements as his claims. No regulator or trial registry confirms them.

How many people have a Neuralink implant

The most recent count Neuralink has published is 21. Its January 28, 2026 update counts "21 Neuralnauts enrolled in trials worldwide" as of that date. The company has not posted a newer figure on its site as of early November 2026.

The same update says implants grew from three people in 2024 to several a month in 2025. It also says the company has had zero serious device-related adverse events. That is the company’s own safety claim, not an independent review.

Neuralink trial sites and countries

Neuralink’s trials page names its partner centers. They include Barrow Neurological Institute, University Health Network, University of Miami Health System, UT Southwestern Medical Center and University College London Hospitals. ClinicalTrials.gov lists these studies with Neuralink as sponsor:

Study What it tests Listed sites Registry ID
PRIME Computer control with the N1 and R1 Phoenix and Miami, US NCT06429735
CAN-PRIME Same, in Canada Toronto NCT06700304
GB-PRIME Same, in the UK London and Newcastle NCT07127172
UAE-PRIME Same, in the UAE Abu Dhabi NCT06992596
CONVOY Controlling an assistive robotic arm Phoenix, US NCT06710626
VOICE Speech from attempted speaking Dallas, US NCT07224256

Registry entries as of November 2, 2026. Each is a feasibility study with a small planned enrollment, from 3 to 15 people. Neuralink’s own Telepathy page lists Canada, the UK and the US, but not the UAE.

What Neuralink is not yet

Neuralink’s own pages say its devices “are investigational and have not been approved by the FDA or other regulatory authorities.” There is no product to buy and no published price.

A few other limits matter here:

  • Eligibility is narrow. The Telepathy study is for adults with paralysis in all four limbs from spinal cord injury, ALS or brain stem stroke. The speech study is for adults with severe speech impairment.
  • Device support is narrow. Control works mainly on a provided MacBook today.
  • Next-generation hardware is a plan. Neuralink’s January update says it is moving from 1,000 to 3,000 electrodes and testing ways to keep threads in place. It does not give a date or a product name.

What Neuralink means for accessible digital products

This part touches our readers’ work today. The Telepathy page says participants use a "mind-controlled mouse." They point and click, without perfect aim or unlimited time.

The W3C’s page on physical disabilities already lists the barriers. They include small click areas, short time limits and mouse-only designs. Several WCAG 2.2 criteria fit how a BCI user works:

  • Target Size (Minimum), 2.5.8, Level AA. The W3C says pointer targets should be at least 24 by 24 CSS pixels, with exceptions.
  • Dragging Movements, 2.5.7, Level AA. Anything done by dragging should also work with single clicks. The W3C names head pointers and eye gaze as inputs that make dragging hard.
  • Timing Adjustable, 2.2.1, Level A. Users must be able to turn off, adjust or extend time limits. Session timeouts on donation and membership forms are the usual offender.
  • Keyboard access, 2.1.1, Level A. Some BCI setups drive a device through switch or keyboard-style input. Apple said in May 2025 that it "will add a new protocol to support Switch Control for Brain Computer Interfaces (BCIs)".

None of this is new work. It is the same checklist in our plain guide to web accessibility and our WCAG 2.2 explainer. The difference is that a new group of users now depends on it. For disability and accessibility organizations, BCIs are one more input method to name in testing plans, alongside eye gaze, switches and voice.

We saw the same pattern with Gemini’s Guided Vision and with the physical AI devices now reaching homes. New hardware still lands on the same web pages. Those pages work for it only if they meet the standards.

Frequently Asked Questions

What is Neuralink?

Neuralink is a company founded by Elon Musk that builds a brain-computer interface. Its N1 implant records brain signals and sends them wirelessly to an app that turns them into computer actions. All of its devices are investigational as of November 2026.

What is Neuralink Telepathy?

Telepathy is Neuralink’s name for its first product: computer control by thought. Participants imagine moving their hand, and the system turns those signals into cursor movement and left, right and middle clicks.

Is Neuralink approved by the FDA?

No. Neuralink says its devices have not been approved by the FDA or other regulators. The FDA allowed human trials under an investigational device exemption in May 2023 and gave Breakthrough Device Designation to Blindsight and to the speech device. Neither designation is an approval.

How many people have a Neuralink implant?

Neuralink’s latest published count is 21 participants, in its January 28, 2026 update. The company has not posted a newer number on its site as of early November 2026.

Where are Neuralink’s trials?

ClinicalTrials.gov lists Neuralink studies in the United States (Phoenix, Miami, Dallas), Canada (Toronto), the United Kingdom (London, Newcastle) and the United Arab Emirates (Abu Dhabi).

Is Blindsight available?

No. The FDA gave Blindsight Breakthrough Device Designation in September 2024, according to Neuralink. No Blindsight trial appears on Neuralink’s trials page or ClinicalTrials.gov as of November 2, 2026. Musk posted on October 30 that it is waiting on regulatory approval.

How much does a Neuralink implant cost?

Neuralink publishes no price, and nothing is for sale. Its trial pages say the device, surgery and study visits are provided at no charge to participants, with travel and lodging supported.

Can Neuralink users browse the web?

Yes, within limits. Neuralink says participants use a cursor and clicks to operate a computer, including messaging, video and coding. Control works mainly on a MacBook the company provides.

What should web teams do about brain-computer interface users?

Follow WCAG 2.2. Large enough click targets, alternatives to dragging, adjustable time limits and full keyboard access help BCI users the same way they help people using eye gaze, switches or head pointers.

Digital Matters

Artificial Intelligence (AI) Desk